Acrobiosystems Co.,Ltd. (SHE:301080)

Market Cap	7.73B +57.0%
Revenue (ttm)	887.21M +29.4%
Net Income	171.25M +28.0%
EPS	1.04 +32.4%
Shares Out	167.18M
PE Ratio	44.52
Forward PE	29.62
Dividend	0.60 (1.30%)
Ex-Dividend Date	n/a

Volume	4,333,035
Average Volume	4,200,254
Open	45.92
Previous Close	46.26
Day's Range	44.40 - 45.94
52-Week Range	33.14 - 71.49
Beta	0.76
RSI	43.26
Earnings Date	Apr 21, 2026

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 869
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301080

Financial Performance

In 2025, Acrobiosystems's revenue was 838.12 million, an increase of 29.94% compared to the previous year's 645.02 million. Earnings were 165.57 million, an increase of 33.70%.